HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol

By Tani Shigemasa   Nagao Ken   Hirayama Atsushi  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys

By van Heek M.   Compton D.S.   Davis H.R.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 79-84

Elsevier

Access to resources Recommend Favorite

Implications of the Obesity Epidemic for Statin Therapy: Shifting Cholesterol Metabolism to a High Synthesis and Low Dietary Absorption State

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 153-166

Bentham Science Publishers

Access to resources Recommend Favorite

The ACAT Inhibitor HL-004 Inhibits Cholesterol Absorption and Lowers Serum Cholesterol in Rats - stimulation of bile acid production by HL-004

By Asami Y.   Kondo Y.   Murakami S.   Araki H.   Tsuchida K.   Higuchi S.  

General Pharmacology, Vol. 31, Iss. 4, 1998-10 ,pp. : 593-596

Elsevier

Access to resources Recommend Favorite

Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

By Hajri T.   Chanussot F.   Ferezou J.   Riottot M.   Lafont H.   Laruelle C.   Lutton C.  

European Journal of Pharmacology, Vol. 320, Iss. 1, 1997-02 ,pp. : 65-71

Elsevier

Access to resources Recommend Favorite